Biomaterials for Orthopaedic Diagnostics and Theranostics
- PMID: 34458652
- PMCID: PMC8386480
- DOI: 10.1016/j.cobme.2021.100308
Biomaterials for Orthopaedic Diagnostics and Theranostics
Abstract
Despite widespread use of conventional diagnostic methods in orthopaedic applications, limitations still exist in detection and diagnosing many pathologies especially at early stages when intervention is most critical. The use of biomaterials to develop diagnostics and theranostics, including nanoparticles and scaffolds for systemic or local applications, has significant promise to address these shortcomings and enable successful clinical translation. These developments in both modular and holistic design of diagnostic and theranostic biomaterials may improve patient treatments for myriad orthopaedic applications ranging from cancer to fractures to infection.
Conflict of interest statement
Competing interests There are no competing interests to declare. Declaration of interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Weinstein SL: The Burden of Musculoskeletal Conditions. J Bone Joint Surg Am 2016, 98:1331. - PubMed
-
- Rasker JJ: Rheumatology in general practice. Br J Rheumatol 1995, 34:494–497. - PubMed
-
- Ferguson JL, Turner SP: Bone Cancer: Diagnosis and Treatment Principles. Am Fam Physician 2018, 98:205–213. - PubMed
-
- Kim MS, Lee SY, Cho WH, Song WS, Koh JS, Lee JA, Yoo JY, Shin DS, Jeon DG: Prognostic effects of doctor-associated diagnostic delays in osteosarcoma. Arch Orthop Trauma Surg 2009, 129:1421–1425. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources